Impella use in real-world cardiogenic shock patients: Sobering outcomes.
<h4>Background</h4>Critically ill patients with cardiogenic shock could benefit from ventricular assist device support using the Impella microaxial blood pump. However, recent studies suggested Impella not to improve outcomes. We, therefore, evaluated outcomes and predictors in a real-wo...
Main Authors: | Khaled Q A Abdullah, Jana V Roedler, Juergen Vom Dahl, Istvan Szendey, Hendrik Haake, Lars Eckardt, Albert Topf, Bernhard Ohnewein, Peter Jirak, Lukas J Motloch, Bernhard Wernly, Robert Larbig |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0247667 |
Similar Items
-
Cardiac Arrhythmias in Survivors of Sudden Cardiac Death Requiring Impella Assist Device Therapy
by: Khaled Q. A. Abdullah, et al.
Published: (2021-03-01) -
Impella versus extracorporal life support in cardiogenic shock: a propensity score adjusted analysis
by: Bernhard Wernly, et al.
Published: (2021-04-01) -
Hemodynamic Support Using Percutaneous Transfemoral Impella 5.0 and Impella RP for Refractory Cardiogenic Shock
by: Pratik K. Dalal, et al.
Published: (2019-01-01) -
Impella CP use in patients with non‐ischaemic cardiogenic shock
by: Octavian Maniuc, et al.
Published: (2019-08-01) -
The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock
by: Saeed Tarabichi, et al.
Published: (2020-08-01)